Work Expert (WE) is an independent publishing and referral website. We are not a recruiter, hiring manager, agent or employer, and we are not affiliated with or endorsed by Mercor. Applying takes you to the platform's own website, where we may be recorded as the referring source. We may receive a referral fee at no additional cost to you. Read our full affiliate disclosure →
About the Role
Mercor is partnering with a biotech and pharma research team on expert human-evaluation work — creating and critiquing rubrics that analyze commercial drugs and drug-development programs. We're seeking a pharma commercial / forecasting expert for a paid pilot, with the potential to continue as the work scales.
What You'll Do
Create and critique rubrics that analyze commercial drugs and drug-development programs
Build or critique a launch curve (uptake, peak share, trajectory)
Judge whether a commercial forecast's assumptions (analogs, ramp, peak, loss of exclusivity) are defensible
Apply this across the pilot's set of drug launches
You're a Good Fit If You
US-based pharma commercial / forecasting professional (people from pharma sales teams can work here too)
Familiarity with biotech/pharma development programs
Experience building or critiquing drug launch / uptake models
5+ years in pharma commercial forecasting, analytics, or strategy
Independent contractor engagement. Apply via the link below - Mercor handles onboarding and pays weekly via Stripe or Wise.
Common Questions
Mercor has a reliability rating of very reliable based on the listings we track, with an onboarding time of 1-3 weeks (interview + assessment + trial). See our full Mercor review for the details behind that rating.
Applying takes you to Mercor's own website, where the application is completed. We are not a recruiter or employer and do not process applications directly - we may be recorded as the referring source.
$130-$210/h - Independent contractor engagement. Apply via the link below - Mercor handles onboarding and pays weekly via Stripe or Wise.
Create and critique rubrics that analyze commercial drugs and drug-development programs Build or critique a launch curve (uptake, peak share, trajectory) Judge whether a commercial forecast's assumptions (analogs, ramp, peak, loss of exclusivity) are defensible
